We demonstrate that co-targeting sMIC with a PD1/PD-L1 blockade profoundly enhances tumor-infiltrated CD8 T cells intrinsic function in general, enhances the function and proliferative ability of antigen-specific CD8 T cells in tumors. This evidence concerns the gene CD274 and neoplasm.